Molecular Partners AG (MOLN)
NASDAQ: MOLN · Real-Time Price · USD
4.390
-0.300 (-6.39%)
Mar 20, 2026, 10:48 AM EDT - Market open
Molecular Partners AG Market Cap
Molecular Partners AG has a market cap or net worth of $164.24 million as of March 20, 2026. Its market cap has decreased by -4.82% in one year.
Market Cap
164.24M
Enterprise Value
58.96M
1-Year Change
-4.82%
Ranking
Category
Stock Price
$4.39
Market Cap Chart
Since the IPO on February 21, 2018, Molecular Partners AG's market cap has decreased from $595.47M to $164.24M, a decrease of -72.42%. That is a compound annual growth rate of -14.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 19, 2026 | 169.26M | 5.70% |
| Dec 30, 2025 | 160.13M | -2.96% |
| Dec 30, 2024 | 165.01M | 22.94% |
| Dec 29, 2023 | 134.22M | -38.09% |
| Dec 30, 2022 | 216.81M | -65.56% |
| Dec 30, 2021 | 629.47M | -8.03% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 21, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Galectin Therapeutics | 177.30M |
| Adagene | 176.17M |
| Canton Strategic Holdings | 175.68M |
| Eledon Pharmaceuticals | 174.10M |
| Cartesian Therapeutics | 173.10M |
| ProQR Therapeutics | 172.79M |
| Milestone Pharmaceuticals | 171.67M |
| Tenaya Therapeutics | 169.26M |